CN103385963A - Chinese medicine preparation for treating angina pectoris caused by coronary heart disease - Google Patents

Chinese medicine preparation for treating angina pectoris caused by coronary heart disease Download PDF

Info

Publication number
CN103385963A
CN103385963A CN2013103122472A CN201310312247A CN103385963A CN 103385963 A CN103385963 A CN 103385963A CN 2013103122472 A CN2013103122472 A CN 2013103122472A CN 201310312247 A CN201310312247 A CN 201310312247A CN 103385963 A CN103385963 A CN 103385963A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
medicine preparation
heart disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013103122472A
Other languages
Chinese (zh)
Other versions
CN103385963B (en
Inventor
于军
田丽
田军政
Original Assignee
于军
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 于军 filed Critical 于军
Priority to CN201310312247.2A priority Critical patent/CN103385963B/en
Publication of CN103385963A publication Critical patent/CN103385963A/en
Application granted granted Critical
Publication of CN103385963B publication Critical patent/CN103385963B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to a medicine preparation, and particularly relates to a Chinese medicine preparation for treating angina pectoris caused by coronary heart disease. The Chinese medicine preparation comprises the following raw Chinese medicinal materials in parts by weight: 6-20 parts of radix puerariae, 6-12 parts of flos chrysanthemi, 3-10 parts of dried tangerine peel, 10-15 parts of semen cassiae, 10-15 parts of hawthorn, 6-15 parts of angelica sinensis, 10-15 parts of radix codonopsis, 8-12 parts of curnu cervi pantotrichum, 10-15 parts of manyprickle acanthopanax root, 6-15 parts of lotus seeds, 10-30 parts of poria cocos, 3-9 parts of ligusticum wallichii, 10-15 parts of radix astragali, 7-12 parts of fructus schizandrae, 10-15 parts of safflowers, and 10-15 parts of salviae miltiorrhizae. Proved by observing 98 cases, the total efficiency of patients with the confirmed angina pectoris caused by coronary heart disease is 90.8% after the Chinese medicine preparation is taken for one month.

Description

Treatment coronary heart disease causes anginal Chinese medicine preparation
Technical field
The invention belongs to a kind of pharmaceutical product, particularly a kind of coronary heart disease for the treatment of causes anginal Chinese medicine preparation.
Background technology
Angina pectoris is a kind of by coronary insufficiency, and cardiac muscle causes with anoxia with temporary transient ischemia sharply that the squeezing of paroxysmal shirtfront is felt or pain is the clinical disease of characteristics.The outbreak of primary disease many tired, exciting, catch cold, be satiated with food, during smoking.
The most frequently used method is to take nitroglycerine tablets.In addition medicine also has beta-Blocking agent such as propranolol, calcium ion antagonist such as nifedipine, diltiazem.At present, nitroglycerin has had membranous patch and oral spray.Membranous patch is used in left front chest outward, and the drug percutaneous skin evenly absorbs, and continues the antianginal effect of performance in 24 hours.Oral spray is little because of consumption, absorbs sooner, and side effect is little and be subject to patient and welcome.Above these two kinds of dosage form prices are more expensive, are unfavorable for promoting the use of.SUXIAO JIUXIN WAN is Chinese medicine preparation, take during angina pectoris attacks in 10-15 grain number minute and take effect, but this medicine is long-term taking also. other are as medicine long-term takings such as storax pill for treating coronary heart disease, FUFANG DANSHEN PIAN, Xinnao Shutongs, can play the effect of the logical coronary circulation of relaxing, generally according to self-condition, select wherein 1,2 kind.Though the satisfied medicine of angina pectoris therapeutic effect is various in style, though long-acting single nitro isosorbide can be kept nearly 20 hours of effect, but clinical practice still has certain disadvantage, and external product is expensive, and how patient's side effect such as excuse pain, flush sometimes can not bear.
Summary of the invention
The object of the invention is to provide a kind of coronary heart disease for the treatment of and causes anginal Chinese medicine preparation.
Specifically, treatment coronary heart disease causes anginal Chinese medicine preparation, and it is made by following weight portion raw material of Chinese medicine:
Radix Puerariae 6-20, Flos Chrysanthemi 6-12, Pericarpium Citri Reticulatae 3-10; Semen Cassiae 10-15, Fructus Crataegi 10-15, Radix Angelicae Sinensis 6-15, Radix Codonopsis 10-15, Cornu Cervi Pantotrichum 8-12, Radix Et Caulis Acanthopanacis Senticosi 10-15, Semen Nelumbinis 6-15, Poria 10-30, Rhizoma Chuanxiong 3-9, the Radix Astragali 10-15, Fructus Schisandrae Chinensis 7-12, Flos Carthami 10-15, Radix Salviae Miltiorrhizae 10-15.
Preferential treatment coronary heart disease of recommending causes anginal Chinese medicine preparation, and it is to be made by following weight portion raw material of Chinese medicine:
Radix Puerariae 12, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 6; Semen Cassiae 12, Fructus Crataegi 12, Radix Angelicae Sinensis 11, Radix Codonopsis 12, Cornu Cervi Pantotrichum 10, Radix Et Caulis Acanthopanacis Senticosi 12, Semen Nelumbinis 9, Poria 20, Rhizoma Chuanxiong 5, the Radix Astragali 12, Fructus Schisandrae Chinensis 9, Flos Carthami 12, Radix Salviae Miltiorrhizae 12.
Described treatment coronary heart disease causes anginal Chinese medicine preparation, and it is to make pill or powder or capsule after all components is cleaned mixing.
Each component effect of the present invention is as follows:
Radix Puerariae-expelling pathogenic factors from muscles for reducing heat, promoting the production of body fluid to quench thirst, treating measles, yang invigorating antidiarrheal;
Flos Chrysanthemi-dispelling wind and heat pathogens, suppressing the hyperactive liver improving eyesight;
Pericarpium Citri Reticulatae-drying dampness to eliminate phlegm, regulating qi-flowing for strengthening spleen;
Semen Cassiae-liver heat removing kidney tonifying, dispelling pathogenic wind for improving eyesight, blood pressure lowering relieving constipation;
Fructus Crataegi-promoting digestion and removing stagnation, antidiarrheal dysentery, dispelling the stagnated QI blood stasis dispelling, blood pressure lowering;
Radix Angelicae Sinensis-tonifying blood and regulating menstruation, promoting blood circulation and stopping pain, loosening bowel to relieve constipation;
Radix Codonopsis-invigorating the spleen and replenishing QI, nourishing blood to promote the production of body fluid;
Radix Ginseng-QI invigorating emergency treatment of collapse, benefit strengthening spleen and lung, promoting the production of body fluid to quench thirst, the mind calming and mentality promoting;
Cornu Cervi Pantotrichum-kidney-replenishing, benefiting essence-blood, bone and muscle strengthening;
Radix Et Caulis Acanthopanacis Senticosi-replenishing QI to invigorate the spleen, tonifying the kidney for tranquilization;
Semen Nelumbinis-spleen reinforcing antidiarrheal, tranquilizing by nourishing the heart, supplementing the kidney to control the nocturnal;
Poria-promoting diuresis to eliminate damp pathogen, spleen invigorating invigorating middle warmer, mind tranquilizing and the heart calming;
Rhizoma Chuanxiong-blood-activating and qi-promoting, wind-expelling pain-stopping;
The Radix Astragali-tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, take off skin ulcer granulation promoting, inducing diuresis to remove edema;
Fructus Schisandrae Chinensis-astringing the lung, nourishing kidney, promote the production of body fluid, receive antiperspirant, arresting seminal emission;
Flos Carthami-invigorate blood circulation logical muscle, stasis-dispelling and pain-killing;
Radix Salviae Miltiorrhizae-blood circulation promoting and blood stasis dispelling, relieving restlessness are calmed the nerves, reducing swelling and alleviating pain.
Advantage of the present invention adopts natural material, has warming YANG activating QI, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving effect, and vascular plaque is had and reduces or disappear, and makes coronary artery unobstructed, thereby makes patients with coronary heart disease reach the therapeutic purposes of rehabilitation.Its compatibility is comprehensive simultaneously, and coronary heart disease is caused that angina pectoris treatment is rapid-action, and relatively the Western medicine toxic and side effects is less.
The specific embodiment
Formula 1: Radix Puerariae 6, Flos Chrysanthemi 12, Pericarpium Citri Reticulatae 3; Semen Cassiae 15, Fructus Crataegi 10, Radix Angelicae Sinensis 15, Radix Codonopsis 10, Cornu Cervi Pantotrichum 12, Radix Et Caulis Acanthopanacis Senticosi 10, Semen Nelumbinis 15, Poria 10, Rhizoma Chuanxiong 9, the Radix Astragali 10, Fructus Schisandrae Chinensis 12, Flos Carthami 10, Radix Salviae Miltiorrhizae 15.
Formula 2: Radix Puerariae 20, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 10; Semen Cassiae 10, Fructus Crataegi 15, Radix Angelicae Sinensis 6, Radix Codonopsis 15, Cornu Cervi Pantotrichum 8, Radix Et Caulis Acanthopanacis Senticosi 15, Semen Nelumbinis 6, Poria 30, Rhizoma Chuanxiong 3, the Radix Astragali 15, Fructus Schisandrae Chinensis 7, Flos Carthami 15, Radix Salviae Miltiorrhizae 10.
Formula 3: Radix Puerariae 12, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 6; Semen Cassiae 12, Fructus Crataegi 12, Radix Angelicae Sinensis 11, Radix Codonopsis 12, Cornu Cervi Pantotrichum 10, Radix Et Caulis Acanthopanacis Senticosi 12, Semen Nelumbinis 9, Poria 20, Rhizoma Chuanxiong 5, the Radix Astragali 12, Fructus Schisandrae Chinensis 9, Flos Carthami 12, Radix Salviae Miltiorrhizae 12.
Preparation method: mix after above-mentioned each prescription drug cleaning-drying, pulverize and to make pill or powder or capsule and all can.
Instructions of taking: every day three times, each former medicine of 6-9 gram.
Treatment by Chinese herbs angina pectoris clinical report of the present invention
Observe altogether coronary heart disease from January, 2013 in June, 2011 and cause angina pectoris 98 examples, observed result is as follows:
One, physical data
98 routine patients with coronary heart disease male 56, women 42 people, 49-78 years old ages, 79 routine complicated hypertension histories, the course of disease is mostly 4-9 years, 48 examples>10 year.
Treating Stable Angina Pectoris of Coronary Artery Disease 61 examples, unstable angina 19 examples, angina pectoris 18 examples after heart infarction.The angina pectoris degree is sought unity of standard according to domestic Angina Pectoris from Coronary Artery Disease with Therapy of Combination of TCM with Western Medicine cooperative groups, slight 39 examples; Moderate 47 examples; Severe 12 examples.
Two, observational technique
Fill in unified observation table and observed by the special messenger, stop any at least one week of angina pectoris medicine, 69 example observation cases due to illness feelings need to contain nitroglycerin,<3 slices/day simultaneously.The nitroglycerin tongue contains exception need count the item records such as every consumption per day (sheet/day) treatment before measurement platelet white blood cell count, GPT, blood glucose, BUN, creatinine, routine urinalysis, cholesterol, triglyceride and high density lipoprotein, electrocardiogram.
Each oral the inventive method of all patients: every day three times, each former medicine of 6-9 gram.Preparation of the present invention is: Radix Puerariae 12, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 6; Semen Cassiae 12, Fructus Crataegi 12, Radix Angelicae Sinensis 11, Radix Codonopsis 12, Cornu Cervi Pantotrichum 10, Radix Et Caulis Acanthopanacis Senticosi 12, Semen Nelumbinis 9, Poria 20, Rhizoma Chuanxiong 5, the Radix Astragali 12, Fructus Schisandrae Chinensis 9, Flos Carthami 12, Radix Salviae Miltiorrhizae 12.All components in gram heavily.Mix after each prescription drug cleaning-drying, pulverizing is made powder and is taken.
One week was a course for the treatment of, the above-mentioned item inspection of check after treatment, and the unification of observation table is gathered to array data by the special messenger makes brief summary.
Three, curative effect judging standard
Produce effects: " breathe hard, pained transference cure or obviously alleviate, other double disease and electrocardiogram are stable or progressive to some extent.
Invalid: all diseases and electrocardiogram are unchanged;
Four, result
1, therapeutic effect: produce effects 89 examples, no effect 9.It is 90.8% that the present invention treats angina pectoris clinical symptoms curative effect obvious effective rate;
2, adverse reactions of patients.In 98 examples only 1 example have epigastric discomfort to feel sick, the loss of appetite untoward reaction, do not affect medication treatment, alleviates gradually disappearance in drug administration process, and is abnormal without other.
3, before and after all other treatments, lab testing has no significant change.

Claims (3)

1. treatment coronary heart disease causes anginal Chinese medicine preparation, it is characterized in that being made by following weight portion raw material of Chinese medicine:
Radix Puerariae 6-20, Flos Chrysanthemi 6-12, Pericarpium Citri Reticulatae 3-10; Semen Cassiae 10-15, Fructus Crataegi 10-15, Radix Angelicae Sinensis 6-15, Radix Codonopsis 10-15, Cornu Cervi Pantotrichum 8-12, Radix Et Caulis Acanthopanacis Senticosi 10-15, Semen Nelumbinis 6-15, Poria 10-30, Rhizoma Chuanxiong 3-9, the Radix Astragali 10-15, Fructus Schisandrae Chinensis 7-12, Flos Carthami 10-15, Radix Salviae Miltiorrhizae 10-15.
2. treatment coronary heart disease according to claim 1 causes anginal Chinese medicine preparation, it is characterized in that being made by following weight portion raw material of Chinese medicine:
Radix Puerariae 12, Flos Chrysanthemi 6, Pericarpium Citri Reticulatae 6; Semen Cassiae 12, Fructus Crataegi 12, Radix Angelicae Sinensis 11, Radix Codonopsis 12, Cornu Cervi Pantotrichum 10, Radix Et Caulis Acanthopanacis Senticosi 12, Semen Nelumbinis 9, Poria 20, Rhizoma Chuanxiong 5, the Radix Astragali 12, Fructus Schisandrae Chinensis 9, Flos Carthami 12, Radix Salviae Miltiorrhizae 12.
3. treatment coronary heart disease according to claim 1 causes anginal Chinese medicine preparation, makes pill or powder or capsule after it is characterized in that all components is cleaned mixing.
CN201310312247.2A 2013-07-23 2013-07-23 Chinese medicine preparation for treating angina pectoris caused by coronary heart disease Expired - Fee Related CN103385963B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310312247.2A CN103385963B (en) 2013-07-23 2013-07-23 Chinese medicine preparation for treating angina pectoris caused by coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310312247.2A CN103385963B (en) 2013-07-23 2013-07-23 Chinese medicine preparation for treating angina pectoris caused by coronary heart disease

Publications (2)

Publication Number Publication Date
CN103385963A true CN103385963A (en) 2013-11-13
CN103385963B CN103385963B (en) 2014-08-13

Family

ID=49530498

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310312247.2A Expired - Fee Related CN103385963B (en) 2013-07-23 2013-07-23 Chinese medicine preparation for treating angina pectoris caused by coronary heart disease

Country Status (1)

Country Link
CN (1) CN103385963B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104645249A (en) * 2015-03-17 2015-05-27 山东省立医院 Medicine for treating coronary heart disease and angina
CN105920296A (en) * 2016-04-29 2016-09-07 王志敏 Traditional Chinese medicine preparation for adjuvant treatment of angina pectoris in qi-and-yin-deficiency type coronary heart diseases, and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1437959A (en) * 2002-02-10 2003-08-27 杨志东 Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method
CN102145128A (en) * 2011-03-30 2011-08-10 呼伦贝尔松鹿制药有限公司 Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1437959A (en) * 2002-02-10 2003-08-27 杨志东 Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method
CN102145128A (en) * 2011-03-30 2011-08-10 呼伦贝尔松鹿制药有限公司 Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘德泉: "冠心病的中药运用规律探讨", 《光明中医》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104645249A (en) * 2015-03-17 2015-05-27 山东省立医院 Medicine for treating coronary heart disease and angina
CN105920296A (en) * 2016-04-29 2016-09-07 王志敏 Traditional Chinese medicine preparation for adjuvant treatment of angina pectoris in qi-and-yin-deficiency type coronary heart diseases, and preparation method thereof

Also Published As

Publication number Publication date
CN103385963B (en) 2014-08-13

Similar Documents

Publication Publication Date Title
CN101843661B (en) Chinese medicament for treating angina
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN103385963B (en) Chinese medicine preparation for treating angina pectoris caused by coronary heart disease
CN101843712B (en) Chinese medicament for treating angina
CN101843740B (en) Chinese medicament for treating climacteric syndromes
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843753B (en) Chinese medicament for treating angina
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843717B (en) Chinese medicament for treating coronary disease
CN101850055B (en) Chinese medicament for treating coronary heart diseases
CN101843707B (en) Chinese medicament for treating chronic hepatitis
CN101850017B (en) Chinese medicament for treating asthma
CN101983712A (en) Novel medicament for treating coronary heart disease
CN101843835B (en) Chinese medicament for treating coronary diseases
CN102716434B (en) Medicine for oral use for treating hypotension
CN101850054B (en) Chinese medicament for treating diabetic heart diseases
CN101850034B (en) Chinese medicament for treating angina
CN103721110A (en) Traditional Chinese medicinal prescription with health-care and weight reducing effects and preparation method thereof
CN101843832B (en) Chinese medicament for treating coronary disease
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases
CN101612233A (en) A kind of Chinese medicine preparation of reducing swelling and alleviating pain
CN101843700A (en) Chinese medicament for treating coronary disease
CN101991647A (en) Traditional Chinese medicine for treating diabetic coronary heart diseases
CN101843698A (en) Chinese medicament for treating cervical spondylosis
CN101843719A (en) Chinese medicament for treating pulmonary heart diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140813

Termination date: 20150723

EXPY Termination of patent right or utility model